Acer Medical Inc. (TPEX:6857)
Taiwan · Delayed Price · Currency is TWD 98.00
-1.50 (-1.51%)
Apr 2, 2026, 12:32 PM CST
Acer Medical Revenue
Acer Medical had revenue of 30.12M TWD in the half year ending June 30, 2025, with 311.77% growth. This brings the company's revenue in the last twelve months to 55.10M, up 21.60% year-over-year. In the year 2024, Acer Medical had annual revenue of 50.16M with 82.73% growth.
Revenue (ttm)
55.10M
Revenue Growth
+21.60%
P/S Ratio
27.08
Revenue / Employee
n/a
Employees
22
Market Cap
1.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 50.16M | 22.71M | 82.73% |
| Dec 31, 2023 | 27.45M | 14.39M | 110.17% |
| Dec 31, 2022 | 13.06M | 3.43M | 35.66% |
| Dec 31, 2021 | 9.63M | 8.61M | 849.41% |
| Dec 31, 2020 | 1.01M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 20.51B |
| Bora Pharmaceuticals | 19.01B |
| PharmaEssentia | 15.63B |
| Cowealth Medical Holding | 2.96B |
| Arich Enterprise | 1.55B |
| Bioptik Technology Incorporation | 837.19M |
| Diamond Biotechnology | 698.11M |
| GenMont Biotech Incorporation | 401.23M |